Skip to main content

Table 2 Perceptions of factors affecting the initiation of patent challenges

From: Perceived impact of the patent linkage system on pharmaceutical market from the viewpoint of the domestic manufacturers in South Korea

 

Total

Group 1

Group 2

Group 3

Market size of the originator drug

1.56 (0.63)

1.52 (0.66)

1.82 (0.39)

1.29 (0.70)

Expectations for succeeding in litigation

1.18 (0.90)

1.43 (0.58)

1.09 (1.00)

0.57 (1.18)

Expectations for manufacturing a generic drug

1.03 (0.80)

0.90 (0.92)

1.27 (0.62)

1.00 (0.53)

Sales force of a manufacturer

0.87 (0.82)

0.86 (0.77)

1.09 (0.90)

0.57 (0.73)

Market power of a manufacture

0.85 (0.74)

1.00 (0.62)

0.45 (0.89)

1.00 (0.53)

Product portfolios of a manufacturer

0.79 (0.76)

1.00 (0.69)

0.73 (0.86)

0.29 (0.45)

Expectations for collaboration with other manufacturers

0.69 (0.99)

0.62 (0.90)

1.18 (0.94)

0.14 (0.99)

Expected cost of a court litigation

-0.13 (0.88)

-0.29 (0.76)

0.00 (1.04)

0.14 (0.83)